Acrivon TherapeuticsACRV
13F holders, Q4 2024 (December 31)63holders +8
7new positions
5sold out
2famous investors
$6.02avg. 13F price*
At the end of Q4 2024, 63 institutions reported holding Acrivon Therapeutics Inc. (ACRV) in their 13F filings, up 8 from Q3 2024. 7 opened new positions and 5 sold out. The largest holders were Ra Capital Management, L.P. ($50.2M), Perceptive Advisors LLC ($32.3M) and Sands Capital Alternatives, LLC ($12.8M). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Acrivon Therapeutics Inc.
- CUSIP
- 004890109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $223K |
| Exits | 5 | $1.4M |
All 13F filers, Q3 2024 → Q4 2024: 345,675 shares bought and 473,514 shares sold, net −127,839 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 63 holders
| Ra Capital Management, L.P. | 0.67% | No change | 8,340,508 | $50.2M |
| Perceptive Advisors LLC | 0.90% | No change | 5,360,858 | $32.3M |
| Sands Capital Alternatives, LLC | 2.78% | No change | 2,122,605 | $12.8M |
| Citadel Advisors | 0.01% | Reduce -1.0% | 2,119,646 | $12.8M |
| BlackRock, Inc. | 0.00% | Add +20.1% | 945,496 | $5.7M |
| Wellington Management Group LLP | 0.00% | No change | 888,130 | $5.3M |
| Vanguard Group Inc. | 0.00% | Add +5.3% | 671,625 | $4.0M |
| Marshall Wace, LLP | 0.00% | Reduce -26.2% | 597,794 | $3.6M |
| Acorn Capital Advisors, LLC | 1.31% | — | 405,237 | $2.4M |
| Geode Capital Management, LLC | 0.00% | Reduce -0.2% | 301,389 | $1.8M |
| Goldman Sachs Group Inc. | 0.00% | Add +19.9% | 237,552 | $1.4M |
| State Street Corp. | 0.00% | Add +4.7% | 236,601 | $1.4M |
| Northern Trust Corp. | 0.00% | Add +11.3% | 117,323 | $706K |
| Charles Schwab Investment Management Inc. | 0.00% | Reduce -2.1% | 113,840 | $685K |
| DAFNA Capital Management LLC | 0.17% | No change | 112,414 | $677K |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.02% | Add +29.7% | 102,784 | $619K |
| Bridgeway Capital Management, LLC | 0.01% | Reduce -3.1% | 74,600 | $449K |
| Baker Bros. Advisors LP | 0.00% | No change | 52,885 | $318K |
| Renaissance Technologies | 0.00% | Add +7.6% | 49,400 | $297K |
| Barclays PLC | 0.00% | Add +14.4% | 38,091 | $229K |
| Dimensional Fund Advisors LP | 0.00% | Add +20.2% | 37,063 | $223K |
| Morgan Stanley | 0.00% | Reduce -3.3% | 34,731 | $209K |
| Bank of America Corp. | 0.00% | Add +3.8% | 31,106 | $187K |
| Bank of New York Mellon Corp | 0.00% | Reduce -6.3% | 27,635 | $166K |
| JPMorgan Chase & Co. | 0.00% | Reduce -24.1% | 25,809 | $155K |
| Exchange Traded Concepts, LLC | 0.00% | No change | 20,348 | $122K |
| Rhumbline Advisers | 0.00% | Reduce -0.0% | 17,755 | $107K |
| American Century Companies Inc. | 0.00% | Add +14.2% | 17,588 | $106K |
| Trexquant Investment LP | 0.00% | Reduce -44.5% | 16,871 | $102K |
| Pale Fire Capital SE | 0.02% | New | 15,235 | $92K |
| UBS Group AG | 0.00% | Add +151.1% | 14,217 | $86K |
| Nuveen Asset Management, LLC | 0.00% | Reduce -48.0% | 13,402 | $81K |
| Marex Group Ltd | 0.00% | No change | 13,187 | $79K |
| Citigroup Inc. | 0.00% | Add +9.9% | 12,332 | $74K |
| Corton Capital Inc. | 0.04% | New | 12,159 | $73K |
| Wealthedge Investment Advisors, LLC | 0.03% | — | 10,857 | $65K |
| AAF Wealth Management, LLC | 0.03% | No change | 10,678 | $64K |
| Wells Fargo & Company | 0.00% | Add +27.9% | 6,933 | $42K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Add +4.7% | 6,775 | $41K |
| China Universal Asset Management Co., Ltd. | 0.00% | New | 6,602 | $40K |
| Corebridge Financial, Inc. | 0.00% | Reduce -7.0% | 5,873 | $35K |
| FMR LLC | 0.00% | Add +13.6% | 2,933 | $18K |
| New York State Common Retirement Fund | 0.00% | No change | 2,314 | $14K |
| BNP Paribas Financial Markets | 0.00% | New | 1,941 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -62.9% | 1,766 | $11K |
| Royal Bank of Canada | 0.00% | Add +28.3% | 1,638 | $10K |
| Mirae Asset Global Investments Co., Ltd. | 0.00% | New | 1,038 | $6K |
| California State Teachers Retirement System | 0.00% | No change | 856 | $5K |
| Legal & General Group Plc | 0.00% | No change | 839 | $5K |
| STRS Ohio | 0.00% | No change | 800 | $5K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 695 | $4K |
| GF Fund Management Co. LTD. | 0.00% | — | 654 | $4K |
| Redwood Park Advisors LLC | 0.00% | — | 500 | $3K |
| Sterling Capital Management LLC | 0.00% | Add +983.8% | 401 | $2K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 400 | $2K |
| Amalgamated Bank | 0.00% | No change | 378 | $2K |
| Russell Investments Group, Ltd. | 0.00% | Reduce -13.6% | 223 | $1K |
| Nisa Investment Advisors, LLC | 0.00% | New | 100 | $602 |
| SBI Securities Co., Ltd. | 0.00% | — | 74 | $445 |
| GAMMA Investing LLC | 0.00% | New | 34 | $205 |
| R Squared Ltd | 0.00% | — | 20 | $120 |
| Cwm, LLC | 0.00% | Reduce -10.9% | 41 | $0 |
| Capital Advisors, Ltd. LLC | 0.00% | No change | 48 | $0 |
"% of holder's portfolio" is ACRV's weight in each manager's 13F, not the share of Acrivon Therapeutics Inc. the manager owns.